Literature DB >> 7399327

Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the Presidential Panel at the 1979 Annual Meeting of the Society of Gynecologic Oncologists.

.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7399327     DOI： 10.1016/0090-8258(80)90071-2

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  7 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  Chemotherapy for advanced recurrent carcinoma of the cervix. A report on the treatment of 22 patients.

Authors:  K von Maillot; I M Ranger
Journal:  Arch Gynecol       Date:  1982

3.  Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up.

Authors:  Daniela Luvero; Francesco Plotti; Alessia Aloisi; Stella Capriglione; Roberto Ricciardi; Andrea Miranda; Salvatore Lopez; Giuseppe Scaletta; Giovanna De Luca; Pierluigi Benedetti-Panici; Roberto Angioli
Journal:  Med Oncol       Date:  2016-08-30       Impact factor: 3.064

4.  Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications.

Authors:  M Chatani; T Nose; N Masaki; T Inoue
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

5.  Cost-utility analysis of treatments for stage IB cervical cancer.

Authors:  Kanyarat Katanyoo; Naiyana Praditsitthikorn; Siriwan Tangjitgamol; Sumonmal Manusirivithaya; Busaba Supawattanabodee
Journal:  J Gynecol Oncol       Date:  2014-04-09       Impact factor: 4.401

6.  Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy.

Authors:  Sang-Won Kim; Mison Chun; Hee-Sug Ryu; Suk-Joon Chang; Tae Wook Kong; Young-Taek Oh; Seung Hee Kang
Journal:  BMC Cancer       Date:  2017-04-28       Impact factor: 4.430

7.  The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee.

Authors:  Masae Ikeda; Masako Shida; Shogo Shigeta; Satoru Nagase; Fumiaki Takahashi; Wataru Yamagami; Hidetaka Katabuchi; Nobuo Yaegashi; Daisuke Aoki; Mikio Mikami
Journal:  J Gynecol Oncol       Date:  2021-05       Impact factor: 4.401
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.